Mayer Rokitansky Kuster Hauser Syndrome
9
4
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
Uterine Transplant for Women With Absolute Uterine Factor Infertility (AUFI)
Clinical and Imaging Features in MRKH Syndrome
The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial
Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
Neovaginoplasty Using Photoinduced-imine-crosslink Hydrogel in MRKH Patients
Uterus Transplantation From a Multi-organ Donor
Quality of Life and Sexual Function in Vaginal Aplasia Patients After Davydov Procedure
Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study
Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome